•
Jun 30, 2021

iTeos Therapeutics Q2 2021 Earnings Report

EPS
-$0.75
Previous year: -$29.5
-97.5%
Cash and Equivalents
$303M
Previous year: $137M
+121.3%
Free Cash Flow
-$18.7M
Total Assets
$319M

iTeos Therapeutics

iTeos Therapeutics